These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38699985)

  • 1. Spectrum of renal disease in scleroderma other than scleroderma renal crisis: A review of the literature.
    Farrukh L; Steen V; Shapiro L; Faddoul G; Mehta S
    Clin Nephrol; 2024 Aug; 102(2):97-106. PubMed ID: 38699985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of kidney involvement in systemic sclerosis: From scleroderma renal crisis to subclinical renal vasculopathy.
    Gigante A; Leodori G; Pellicano C; Villa A; Rosato E
    Am J Med Sci; 2022 Nov; 364(5):529-537. PubMed ID: 35537505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-neutrophil antibody associated vasculitis in systemic sclerosis.
    Arad U; Balbir-Gurman A; Doenyas-Barak K; Amit-Vazina M; Caspi D; Elkayam O
    Semin Arthritis Rheum; 2011 Oct; 41(2):223-9. PubMed ID: 21277620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Involvement in Systemic Sclerosis: An Update.
    Chrabaszcz M; Małyszko J; Sikora M; Alda-Malicka R; Stochmal A; Matuszkiewicz-Rowinska J; Rudnicka L
    Kidney Blood Press Res; 2020; 45(4):532-548. PubMed ID: 32521536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review.
    Wu R; Su J; Zou YR; Zhu J
    Eur J Med Res; 2021 Mar; 26(1):30. PubMed ID: 33789719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal and extra-renal involvement in sclerodermia].
    Visconti L; Atteritano M; Buemi M; Santoro D
    G Ital Nefrol; 2014; 31(5):. PubMed ID: 25315720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication.
    Moinzadeh P; Kuhr K; Siegert E; Blank N; Sunderkoetter C; Henes J; Krusche M; Schmalzing M; Worm M; Schmeiser T; Günther C; Aberer E; Susok L; Riemekasten G; Kreuter A; Zeidler G; Juche A; Hadjiski D; Müller-Ladner U; Gaebelein-Wissing N; Distler JHW; Sárdy M; Krieg T; Hunzelmann N
    J Rheumatol; 2020 Feb; 47(2):241-248. PubMed ID: 30936287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANCA-associated vasculitis in scleroderma: A renal perspective
.
    Kant S; Shah AA; Hummers LK; Wigley FM; Geetha D
    Clin Nephrol; 2018 Dec; 90(6):413-418. PubMed ID: 30106367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis.
    Iliopoulos G; Daoussis D
    Rheumatol Int; 2021 Jul; 41(7):1203-1208. PubMed ID: 33844037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors of Renal Involvement in Systemic Sclerosis.
    Rosato E; Gigante A; Barbano B; Gasperini ML; Cianci R; Muscaritoli M
    Kidney Blood Press Res; 2018; 43(3):682-689. PubMed ID: 29763902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studying the Role of C5-Inhibition Therapy in Scleroderma Renal Crisis-Induced Thrombotic Microangiopathy - A Review of Literature.
    Farrukh L; Steen VD; Shapiro L; Mehta S
    Semin Arthritis Rheum; 2023 Dec; 63():152256. PubMed ID: 37689027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta-analysis.
    Xiong A; Cao Y; Xiang Q; Song Z; Zhang Y; Zhou S; Qiang Y; Chen H; Hu Z; Cui H; Luo J; Wang Y; Yang Y; Yang M; Shuai S
    J Clin Pharm Ther; 2022 Jun; 47(6):722-731. PubMed ID: 35233779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management.
    Shanmugam VK; Steen VD
    Curr Opin Rheumatol; 2012 Nov; 24(6):669-76. PubMed ID: 22955019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal involvement in systemic sclerosis.
    Scheen M; Dominati A; Olivier V; Nasr S; De Seigneux S; Mekinian A; Issa N; Haidar F
    Autoimmun Rev; 2023 Jun; 22(6):103330. PubMed ID: 37031831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scleroderma renal crisis.
    Bose N; Chiesa-Vottero A; Chatterjee S
    Semin Arthritis Rheum; 2015 Jun; 44(6):687-94. PubMed ID: 25613774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney involvement in systemic sclerosis.
    Steen VD
    Presse Med; 2014 Oct; 43(10 Pt 2):e305-14. PubMed ID: 25174767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis.
    Cole A; Ong VH; Denton CP
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):378-391. PubMed ID: 35648373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANCA in systemic sclerosis, when vasculitis overlaps with vasculopathy: a devastating combination of pathologies.
    Hughes M; Kahaleh B; Denton CP; Mason JC; Matucci-Cerinic M
    Rheumatology (Oxford); 2021 Dec; 60(12):5509-5516. PubMed ID: 33744916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic sclerosis medications and risk of scleroderma renal crisis.
    Gordon SM; Hughes JB; Nee R; Stitt RS; Bailey WT; Little DJ; Edison JD; Olson SW
    BMC Nephrol; 2019 Jul; 20(1):279. PubMed ID: 31345158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.